HomeCompareASLRF vs MRK

ASLRF vs MRK: Dividend Comparison 2026

ASLRF yields 117647.06% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ASLRF wins by $2.4490325826469777e+27M in total portfolio value
10 years
ASLRF
ASLRF
● Live price
117647.06%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.4490325826469777e+27M
Annual income
$2,444,944,443,233,973,000,000,000,000,000,000.00
Full ASLRF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ASLRF vs MRK

📍 ASLRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodASLRFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ASLRF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ASLRF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASLRF
Annual income on $10K today (after 15% tax)
$10,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$2,078,202,776,748,877,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ASLRF beats the other by $2,078,202,776,748,877,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASLRF + MRK for your $10,000?

ASLRF: 50%MRK: 50%
100% MRK50/50100% ASLRF
Portfolio after 10yr
$1.2245162913234889e+27M
Annual income
$1,222,472,221,616,986,500,000,000,000,000,000.00/yr
Blended yield
99.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ASLRF
No analyst data
Altman Z
-0.7
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASLRF buys
0
MRK buys
0
No recent congressional trades found for ASLRF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricASLRFMRK
Forward yield117647.06%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$2.4490325826469777e+27M$56.8K
Annual income after 10y$2,444,944,443,233,973,000,000,000,000,000,000.00$9,798.13
Total dividends collected$2.4487647437542094e+27M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ASLRF vs MRK ($10,000, DRIP)

YearASLRF PortfolioASLRF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,775,406$11,764,705.88$11,206$366.19+$11.76MASLRF
2$12,959,719,951$12,947,120,266.47$12,650$502.35+$12959.71MASLRF
3$13,330,950,797,490$13,317,083,897,142.26$14,407$694.19+$13330950.78MASLRF
4$12,816,648,626,679,364$12,802,384,509,326,052.00$16,585$967.82+$12816648626.66MASLRF
5$11,516,960,722,017,810,000$11,503,246,907,987,263,000.00$19,342$1,363.89+$11516960722017.79MASLRF
6$9,672,833,529,684,261,000,000$9,660,510,381,711,703,000,000.00$22,913$1,947.19+$9672833529684262.00MASLRF
7$7,593,193,937,496,450,000,000,000$7,582,844,005,619,688,000,000,000.00$27,662$2,823.89+$7593193937496450048.00MASLRF
8$5,571,253,617,107,891,000,000,000,000$5,563,128,899,594,770,000,000,000,000.00$34,159$4,173.35+$5.571253617107891e+21MASLRF
9$3,820,691,040,191,121,600,000,000,000,000$3,814,729,798,820,816,600,000,000,000,000.00$43,337$6,308.80+$3.8206910401911215e+24MASLRF
10$2,449,032,582,646,977,800,000,000,000,000,000$2,444,944,443,233,973,000,000,000,000,000,000.00$56,776$9,798.13+$2.4490325826469777e+27MASLRF

ASLRF vs MRK: Complete Analysis 2026

ASLRFStock

Alien Metals Ltd, together with its subsidiaries, engages in the acquisition and development of mineral resource assets. The company explores for copper, zinc, lead, silver, gold, iron ore, and precious metal deposits. The company holds a 100% interest in Vivash Gorge Iron Ore Project located in the Pilbara region of Western Australia. It also holds interest in the Donovan 2 project, the Los Campos project, and the San Celso project located in Mexico; the Elizabeth Hill project, the Munni Munni North project, the Munni Munni PGE project, and the Brockman and Hancock iron project situated in Western Australia; and the Citronen project located in Greenland. The company was formerly known as Arian Silver Corporation and changed its name to Alien Metals Limited in October 2018. Alien Metals Ltd was founded in 2006 and is headquartered in London, the United Kingdom.

Full ASLRF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ASLRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASLRF vs SCHDASLRF vs JEPIASLRF vs OASLRF vs KOASLRF vs MAINASLRF vs JNJASLRF vs ABBVASLRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.